Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

543 ARTÍCULOS , VIENDO DEL 436 AL 450

The oxidatively damaged DNA and amyloid-β oligomer hypothesis of Alzheimer's disease

Sanders OD, Rajagopal L, Rajagopal JA.

Free Radic Biol Med. 2022 Feb 1;179:403-412. doi: 10.1016/j.freeradbiomed.2021.08.019. Epub 2021 Sep 8.

Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease

Abd-Elrahman KS, Ferguson SSG.

Annu Rev Pharmacol Toxicol. 2022 Jan 6;62:235-254. doi: 10.1146/annurev-pharmtox-021821-091747. Epub 2021 Sep 13.

Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimer's Disease

Wan T, Fu M, Jiang Y, Jiang W, Li P, Zhou S.

Neurochem Res. 2022 Feb;47(2):205-217. doi: 10.1007/s11064-021-03448-1. Epub 2021 Sep 13.

Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria

Franzen S, Smith JE, van den Berg E, Rivera Mindt M, van Bruchem-Visser RL, Abner EL, Schneider LS, Prins ND, Babulal GM, Papma JM.

Alzheimers Dement. 2022 Apr;18(4):810-823. doi: 10.1002/alz.12433. Epub 2021 Sep 30.

Accelerated Approval of Aducanumab: Where Do We Stand Now?

Barenholtz Levy H.

Ann Pharmacother. 2022 Jun;56(6):736-739. doi: 10.1177/10600280211050405. Epub 2021 Oct 1.

The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer's disease: a randomized, triple-blind, placebo-controlled trial

Louzada LL, Machado FV, Quintas JL, Ribeiro GA, Silva MV, Mendonça-Silva DL, Gonçalves BSB, Nóbrega OT, Camargos EF.

Neuropsychopharmacology. 2022 Jan;47(2):570-579. doi: 10.1038/s41386-021-01191-3. Epub 2021 Oct 11.

Of education and public policy: Aducanumab

Lundebjerg NE, Hollmann PA, Supiano MA.

J Am Geriatr Soc. 2022 Jan;70(1):81-84. doi: 10.1111/jgs.17523. Epub 2021 Nov 3.

Population pharmacokinetics and standard uptake value ratio of aducanumab, an amyloid plaque-removing agent, in patients with Alzheimer's disease

Kandadi Muralidharan K, Tong X, Kowalski KG, Rajagovindan R, Lin L, Budd Haberlain S, Nestorov I.

CPT Pharmacometrics Syst Pharmacol. 2022 Jan;11(1):7-19. doi: 10.1002/psp4.12728. Epub 2021 Oct 26.

Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer's Disease

Dhapola R, Sarma P, Medhi B, Prakash A, Reddy DH.

Mol Neurobiol. 2022 Jan;59(1):535-555. doi: 10.1007/s12035-021-02612-6. Epub 2021 Nov 2.

Chinese Herbal Medicine Adjusting Brain Microenvironment via Mediating Central Nervous System Lymphatic Drainage in Alzheimer's Disease

Zhou XB, Zhang YX, Zhou CX, Ma JJ.

Chin J Integr Med. 2022 Feb;28(2):176-184. doi: 10.1007/s11655-021-3342-5. Epub 2021 Nov 3.

Therapeutic potential of quinazoline derivatives for Alzheimer's disease: A comprehensive review

Haghighijoo Z, Zamani L, Moosavi F, Emami S.

Eur J Med Chem. 2022 Jan 5;227:113949. doi: 10.1016/j.ejmech.2021.113949. Epub 2021 Oct 27.

Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside

Walia V, Kaushik D, Mittal V, Kumar K, Verma R, Parashar J, Akter R, Rahman MH, Bhatia S, Al-Harrasi A, Karthika C, Bhattacharya T, Chopra H, Ashraf GM.

Mol Neurobiol. 2022 Jan;59(1):657-680. doi: 10.1007/s12035-021-02617-1. Epub 2021 Nov 9.

Accelerated intermittent theta-burst stimulation broadly ameliorates symptoms and cognition in Alzheimer's disease: A randomized controlled trial

Wu X, Ji GJ, Geng Z, Wang L, Yan Y, Wu Y, Xiao G, Gao L, Wei Q, Zhou S, Wei L, Tian Y, Wang K.

Brain Stimul. 2022 Jan-Feb;15(1):35-45. doi: 10.1016/j.brs.2021.11.007. Epub 2021 Nov 6.

An alarm on vitamin D therapy for Alzheimer's disease patients: a case with Alzheimer's disease whose symptoms were exacerbated under chronic use of eldecalcitol

Nakajima-Ohyama KC, Tansho K, Tanimukai H.

Psychogeriatrics. 2022 Jan;22(1):145-148. doi: 10.1111/psyg.12786. Epub 2021 Nov 10.

Transcranial magnetic stimulation for sleep disorders in Alzheimer's disease: A double-blind, randomized, and sham-controlled pilot study

Zhou X, Wang Y, Lv S, Li Y, Jia S, Niu X, Peng D.

Neurosci Lett. 2022 Jan 1;766:136337. doi: 10.1016/j.neulet.2021.136337. Epub 2021 Nov 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias